Astrozen Pharmaceuticals Private Limited, a active private limited company, was established on 09 June 2015 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233MH2015PTC265367. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Lallan Jameedar Singh (Director), Kaushilya Bharti (Director), Indra Jeet Jhinkan Bharti (Director). It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Anandban Chs Blds. No.A1/402, Gaondevi, Thane, Maharashtra, 400602.
U24233MH2015PTC265367
265367
09 June 2015
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Astrozen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lallan Jameedar Singh | Director | 11 Aug 2023 | Current |
| Kaushilya Bharti | Director | 09 Jun 2015 | Current |
| Indra Jeet Jhinkan Bharti | Director | 09 Jun 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Astrozen Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 21.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 666.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Astrozen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2020 | Uco Bank | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Astrozen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Astrozen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astrozen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Lallan Jameedar Singh was appointed as a Director was appointed as a Director on 11 Aug 2023 & has been associated with this company since 2 years 4 months . was documented.
The activity Astrozen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Progress on Astrozen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was documented.
Progress on A charge with Uco Bank amounted to Rs. 1.00 M with Charge ID 100430572 was registered on 24 Nov 2020. was documented.
Progress on Kaushilya Bharti was appointed as a Director was appointed as a Director on 09 Jun 2015 & has been associated with this company since 10 years 6 months . was documented.
Indra Jeet Jhinkan Bharti was appointed as a Director was appointed as a Director on 09 Jun 2015 & has been associated with this company since 10 years 6 months . was recorded as a recent event.
The CIN of Astrozen Pharmaceuticals Private Limited is U24233MH2015PTC265367.
Astrozen Pharmaceuticals Private Limited is headquartered at Anandban Chs Blds. No.A1/402, Gaondevi, Thane, Maharashtra, 400602.
Astrozen Pharmaceuticals Private Limited was incorporated on 09 June 2015.
The current directors of Astrozen Pharmaceuticals Private Limited are
The primary industry of Astrozen Pharmaceuticals Private Limited is Manufacturing.
Astrozen Pharmaceuticals Private Limited is unlisted.
The authorized capital of Astrozen Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Astrozen Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX